what are the problems with glp 1 Is a GLP-1 right for you? Since widespread adoption of GLP-1 receptor agonists like Ozempic, Wegovy and Munjaro for the management of metabolic disease and weight loss, there's been a growing The GLP-1 Agonists and Obesity:

Zhong J, Maiseyeu A, Rajagopalan S

Havas, K

Clinical Scenarios Favoring Monotherapy IGF-1 is 20-30% below the age-adjusted reference range but not severely deficient The patient is age 30% below range) | | Age | 50 | | Prior response to sermorelin | IGF-1 normalized at 12 weeks | IGF-1 unchanged or minimally changed | | Pituitary reserve assessment | Normal GH stimulation test | Subnormal peak GH on stimulation | | Cost tolerance | Lower | Higher | | Concurrent anabolic goals | Baseline wellness | Body recomposition, recovery | Dosing the Sermorelin + CJC-1295 Protocol No published RCT has evaluated the combination protocol head-to-head against monotherapy in adults

The modern diet, individual microbiome variations, and lifestyle factors have created a widespread challenge of butyrate insufficiency